What strategies are the most effective in optimizing IVF outcome in patients with advanced maternal age?

References

• Dunson DB, Colombo B, Baird DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum. Reprod.17, 1399–1403 (2002).
   PubMed Web of Science ®Google Scholar
• Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum. Reprod.19, 1548–1553 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia JE, Jones GS, Acosta AA, Wright G. HMG/hCG follicular maturation for oocytes aspiration: Phase II, 1981. Fertil. Steril.39, 174–179 (1983).
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; on behalf of the ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod.26, 1616–1624 (2011).
   PubMed Web of Science ®Google Scholar
• Goverde AJ, McDonnell J, Schats R, Vermeiden JP, Homburg R, Lambalk CB. Ovarian response to standard gonadotrophin stimulationfor IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility. Hum. Reprod.20, 1573–1577 (2005).
   PubMedGoogle Scholar
• El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve – an eight year study. Hum. Reprod.17, 1519–1524 (2002).
   PubMed Web of Science ®Google Scholar
• Keay SD, Barlow R, Eley A, Masson GM, Anthony FW, Jenkins JM. The relation between immunoglobulin G antibodies to Chlamydia trachomatis and poor ovarian response to gonadotropin stimulation before in vitro fertilization. Fertil. Steril.70, 214–218 (1998).
   PubMed Web of Science ®Google Scholar
• Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil. Steril.90, 1656–1661 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum. Reprod.24, 496–501 (2009).
   PubMed Web of Science ®Google Scholar
• De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet11, 911–921 (2010).
   Google Scholar
• La Marca A, Sighinolfi G, Radi D et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update16, 113–130 (2010).
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update12, 685–718 (2006).
   PubMed Web of Science ®Google Scholar
• Verhagen TE, Hendriks DJ, Bancsi LF, Mol BW, Broekmans FJ. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum. Reprod. Update14, 95–100 (2008).
   PubMed Web of Science ®Google Scholar
• Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antiMüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil. Steril.91, 705–714 (2009).
   PubMed Web of Science ®Google Scholar
• Nyboe Andersen A, Goossens V, Bhattacharya S et al.; European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe, 2005, results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum. Reprod.24, 1267–1287 (2009).
   PubMed Web of Science ®Google Scholar
• Zuzuarregui JL, Meseguer M, Garrido N, Simón C, Pellicer A, Remohí J. Parameters affecting the results in a program of artificial insemination with donor sperm. A 12-year retrospective review of more than 1800 cycles. J. Assist. Reprod. Genet.21, 109–118 (2004).
   Google Scholar
• Belloc S, Cohen-Bacrie P, Benkhalifa M, et al. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod. Biomed. Online17, 392–397 (2008).
   PubMed Web of Science ®Google Scholar
• Pacheco A, Garrido N, Pellicer A et al. Cumulative livebirth rates (CLBR) in intrauterine insemination (IUI) using donor’s sperm related to women’s age: a retrospective study in 7122 cases. Fertil. Steril.94 (2010) (Abstract S256).
   Google Scholar
• Serour G, Mansour R, Serour A et al. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above. Fertil. Steril.94, 1707–1712 (2010).
   PubMed Web of Science ®Google Scholar
• Geraedts J, Montag M, Magli MC et al. Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Hum. Reprod. DOI: 10.1093/humrep/der294 (2011) (Epub ahead of print).
   Google Scholar
• Guerif F, Lemseffer M, Couet ML, Gervereau O, Ract V, Royere D. Serum antiMüllerian hormone is not predictive of oocyte quality in vitro fertilization. Ann. Endocrinol.70, 230–234 (2009).
   PubMed Web of Science ®Google Scholar
• Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum. Reprod.26(7), 1905–1909 (2011).
   PubMed Web of Science ®Google Scholar
• Edwards RG, Lobo R, Bouchard P. Time to revolutionize ovarian stimulation. Hum. Reprod.11, 917–919 (1996).
   PubMed Web of Science ®Google Scholar
• Munne S, Magli C, Adler A et al. Treatment-related chromosome abnormalities in human embryos. Hum. Reprod.12, 780–784 (1997).
   PubMed Web of Science ®Google Scholar
• Katz-Jaffe MG, Trounson AO, Cram DS. Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions. Fertil. Steril.84, 634–643 (2005).
   PubMed Web of Science ®Google Scholar
• Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum. Reprod.14(Suppl. 2), 107–111 (1999).
   PubMed Web of Science ®Google Scholar
• Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum. Reprod.16, 221–225 (2001).
   PubMedGoogle Scholar
• Van der Auwera I, D’Hooghe T. Superovulation of female mice delays embryonic and fetal development. Hum. Reprod.16, 1237–1243 (2001).
   PubMedGoogle Scholar
• Baart EB, Martini E, Eijkemans MJ et al. Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum. Reprod.22, 980–988 (2007).
   PubMed Web of Science ®Google Scholar
• Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst. Rev.1, CD003973 (2003).
   Google Scholar
• Mochtar MH, Van der Veen, Ziech M, van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst. Rev.2, CD005070 (2007).
   Google Scholar
• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil. Steril.95, 1031–1036 (2011).
   PubMed Web of Science ®Google Scholar
• Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin α) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod. Biomed. Online8, 175–182 (2004).
   PubMed Web of Science ®Google Scholar
• Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod. Biomed. Online8, 635–643 (2004).
   PubMed Web of Science ®Google Scholar
• Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil. Steril.87, 542–546 (2007).
   PubMed Web of Science ®Google Scholar
• Suh CS, Jee BC, Choi YM et al. Prognostic implication of apoptosis in human luteinized granulosa cells during IVF-ET. J. Assist. Reprod. Genet.19, 209–214 (2002).
   Google Scholar
• Tilly JL, Kowalski KI, Johnson AL, Hsueh AJ. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology129, 2799–2801 (1991).
   PubMed Web of Science ®Google Scholar
• Bencomo E, Perez R, Arteaga MF et al. Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate. Fertil. Steril.85, 474–480 (2006).
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil. Steril.75, 305–309 (2001).
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Moreno L, Pacheco A et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil. Steril.84, 82–87 (2005).
   PubMed Web of Science ®Google Scholar
• Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertil. Steril.89, 151–156 (2008).
   PubMed Web of Science ®Google Scholar
• Yarali H, Esinler I, Polat M, Bozdag G, Tiras B. Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol. Fertil. Steril.92, 231–235 (2009).
   PubMed Web of Science ®Google Scholar
• Goswami SK, Das T, Chattopadhyay R et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum. Reprod.19, 2031–2035 (2004).
   PubMed Web of Science ®Google Scholar
• Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following treatment with letrozole or letrozole and gonadotropins. Fertil. Steril.88, 665–669 (2005).
   Google Scholar
• Tulandi T, Martin J, Al-Fadhli R et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril.85, 1761–1765 (2006).
   PubMed Web of Science ®Google Scholar
• Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest.101, 2622–2629 (1998).
   PubMed Web of Science ®Google Scholar
• Weil SJ, Vendola K, Zhou J et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J. Clin. Endocrinol. Metab.83, 2479–2485 (1998).
   PubMed Web of Science ®Google Scholar
• Tanbo T, Dale PO, Abyholm T. Recombinant follicle-stimulating hormone stimulates ovarian androgen synthesis in down-regulated ovulatory women. Gynecol. Endocrinol.15, 407–412 (2001).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod. Biol. Endocrinol.9, 116 (2011).
   PubMed Web of Science ®Google Scholar
• Balasch J, Fábregues F, Peñarrubia J et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum. Reprod.21, 1884–1893 (2006).
   PubMed Web of Science ®Google Scholar
• Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique – a prospective, randomized, double-blind study. Hum. Reprod.21, 1204–1211 (2006).
   PubMedGoogle Scholar
• Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum. Reprod.15, 2129–2132 (2000).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod. Biol. Endocrinol.8, 140 (2010).
   PubMed Web of Science ®Google Scholar
• Jacob MH, da R Janner D, Jahn MP, Kucharski LC, Belló-Klein A, Ribeiro MF. Age-related effects of DHEA on peripheral markers of oxidative stress. Cell. Biochem. Funct.28, 52–57 (2010).
   Google Scholar
• Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum. Reprod.25, 2239–2246 (2010).
   PubMed Web of Science ®Google Scholar
• Milán M, Cobo AC, Rodrigo L et al. Redefining advanced maternal age as an indication for preimplantation genetic screening. Reprod. Biomed. Online21, 649–657 (2010).
   PubMed Web of Science ®Google Scholar
• Toner JP, Grainger DA, Frazier LM. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996–1998. Fertil. Steril.78, 1038–1045 (2002).
   PubMed Web of Science ®Google Scholar
• Budak E, Garrido N, Soares SR et al. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil. Steril.88, 342–349 (2007).
   Google Scholar